Global Women’s Health Diagnostics Market Size & Trends Report Segmented by Application (Osteoporosis, OVC, Cervical Cancer, Breast Cancer, Pregnancy & Fertility, Infectious Disease, STD), End User (Hospitals, ASCs, Home Care Settings) Forecast to 2030
The global women’s health diagnostics market is set to witness a growth rate of ~7% in the next 5 years. Increasing prevalence of women’s health disorders, growing awareness and government initiatives, advancements in diagnostic technologies, rising demand for point-of-care and at-home testing, and expanding female geriatric population are some of the key factors driving the women’s health diagnostics market. To learn more about the research report, download a sample report.
Report Overview
Women’s health diagnostics refers to medical tests and screening procedures designed to detect, monitor, and manage health conditions specific to women. These diagnostics cover a broad range of diseases, including breast and cervical cancer, osteoporosis, reproductive and fertility issues, and sexually transmitted infections among others. They utilize advanced technologies such as molecular diagnostics, imaging, next-generation sequencing, and point-of-care testing to enable early detection and personalized treatment and others. With increasing awareness, government initiatives, and technological advancements, women’s health diagnostics play a crucial role in preventive healthcare, improving outcomes, and reducing disease burden through timely and accurate medical intervention.
To learn more about this report, download the PDF brochure
Increasing prevalence of women’s health disorders to propel market demand
The increasing prevalence of women’s health disorders, such as breast cancer, cervical cancer, osteoporosis, and polycystic ovary syndrome, is a major driver of the women’s health diagnostics market. Rising disease prevalence necessitates early detection and continuous monitoring, fueling demand for advanced diagnostic solutions. According to WHO, in 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally, highlighting the need for improved screening technologies. Additionally, growing awareness and government initiatives promoting routine screenings are encouraging higher adoption of diagnostic tests. This trend is driving innovation in molecular diagnostics, imaging, and point-of-care testing, enhancing early disease detection and treatment outcomes.
Advancements in diagnostic technologies are driving the market growth
Advancements in diagnostic technologies are driving the women’s health diagnostics market by improving accuracy, efficiency, and accessibility of disease detection. Innovations such as next-generation sequencing, liquid biopsy, AI-powered imaging, and molecular diagnostics enable early and precise identification of conditions like breast and cervical cancer, osteoporosis, and fertility disorders. Additionally, point-of-care and at-home diagnostic solutions provide faster, more convenient testing. These advancements reduce diagnostic errors, enable personalized treatment, and support preventive healthcare, increasing the adoption of cutting-edge diagnostic tools in women’s health.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global women’s health diagnostics market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Hologic, Inc., Quest Diagnostics Incorporated, Abbott, BD, GE Healthcare, Koninklijke Philips N.V., PerkinElmer, Thermo Fisher Scientific Inc., and BIOMÉRIEUX; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 7% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Application, End User |
| Regional Scope |
|
| Key Companies Mapped | F. Hoffmann-La Roche Ltd, Hologic, Inc., Quest Diagnostics Incorporated, Abbott, BD, GE Healthcare, Koninklijke Philips N.V., PerkinElmer, Thermo Fisher Scientific Inc., and BIOMÉRIEUX among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Women’s Health Diagnostics Market Segmentation
This report by Medi-Tech Insights provides the size of the global women’s health diagnostics market at the regional- and country-level from 2023 to 2030. The report further segments the market based on, application, end user.
Market Size & Forecast (2023-2030), By Application, USD Million
- Osteoporosis Testing
- OVC Testing
- Cervical Cancer Testing
- Breast Cancer Testing
- Pregnancy & Fertility Testing
- Infectious Disease Testing
- STD Testing
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals & Clinics
- Diagnostic and Imaging Centers
- Home Care Settings
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the women’s health diagnostics market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the women’s health diagnostics market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Women’s Health Diagnostics Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Increasing prevalence of women’s health disorders
- Growing awareness and government initiatives
- Advancements in diagnostic technologies
- Rising demand for point-of-care and at-home testing
- Expanding female geriatric population
- Restraints
- High cost of diagnostic imaging systems and procedures
- Lack of skilled professionals
- Limited reimbursement policies
- Social and cultural barriers
- Opportunities
- Expansion in emerging markets
- Integration of AI and ML
- Personalized and genomic medicine
- Increasing collaborations between private and public sectors
- Key Market Trends
- Development of non-invasive tests
- Integration of digital health solutions
- Increasing focus on early detection
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Women’s Health Diagnostics Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Osteoporosis Testing
- OVC Testing
- Cervical Cancer Testing
- Breast Cancer Testing
- Pregnancy & Fertility Testing
- Infectious Disease Testing
- STD Testing
- Others
- Global Women’s Health Diagnostics Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals & Clinics
- Diagnostic and Imaging Centers
- Home Care Settings
- Others
- Global Women’s Health Diagnostics Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Women’s Health Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Women’s Health Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Women’s Health Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Women’s Health Diagnostics Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Women’s Health Diagnostics Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Hoffmann-La Roche Ltd
- Hologic, Inc.
- Quest Diagnostics Incorporated
- Abbott
- BD
- GE Healthcare
- Koninklijke Philips N.V.
- PerkinElmer
- Thermo Fisher Scientific Inc.
- BIOMÉRIEUX
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals and Clinics; Diagnostic Imaging Centers; Home Care Settings; and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
